Rikard Akhtarzand, CEO of ADDvise Group AB (publ) (“ADDvise” or the “Company”), has informed the Company that he has sold 2,500,000 Class B shares in ADDvise, representing approximately 1.3% of total outstanding shares and 18.1% of his total shareholding in the Company, and that he has entered a 180-day lock-up agreement for his remaining shares. The shares were sold in a block trade to Swedish and international investors, including the Company’s Chairman Staffan Torstensson and largest owner Per Åhlgren. Following the transaction, Rikard Akhtarzand holds 2,620,416 Class A shares and 8 658 493 Class B shares.
Rikard Akhtarzand comments: “The divestment is solely made for private financial reasons, and I do not intend to sell additional shares and have therefore agreed to enter a lock-up agreement of 180 days on my remaining shares to emphasize this. The proceeds from the share sale will be used to finance costs related to a divorce. I have great faith in the future of ADDvise Group and I look forward to continuing to lead the company going forward.”
This information is information that ADDvise Group AB is required to disclose under the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on August 22, 2023 at 15:40 CEST.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The Group consists of two business units: Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expanding the business—both geographically and product-wise. ADDvise Group’s shares are listed on Nasdaq First North Premier Growth Market, and Mangold Fondkommission AB, +46 (0)8-503 015 50, CA@mangold.se, is the company’s certified adviser. Further information is available at www.addvisegroup.com.